ASSTON PHARMACEUTICALS LIMITED

APL

Small Cap | Pharmaceuticals
81.34
+1.33 (+1.66%)

Stock price as on 06 Feb 2026 at 15:09 PM

Asston pharmaceuticals limited share price update

As of the latest trading session, Asston Pharmaceuticals Limited share price is currently at ₹81.34, which is up by ₹1.33 from its previous closing. T...

Asston Pharmaceuticals Limited stock performance

Today’s low

₹80

Today’s high

₹83

₹81.34

52 week low

₹75.21

52 week high

₹126

₹81.34
Open
₹80.00
Previous close
₹80.00
Share volume
5,000
Total traded value (Lakh)
₹4.04
Upper circuit
₹96.00
Lower circuit
₹64.00

Asston Pharmaceuticals Limited fundamentals

Market cap (Cr)
₹69.20
P/E ratio (TTM)
17.66
Book value per share
₹45.34
Beta
0
Return on equity
42.28%
Earnings per share (TTM)
₹4.48
Dividend yield
0%
Net profit/quarter (Cr)
₹0.00

Asston Pharmaceuticals Limited financials

(Values in Cr)
Revenue
Net income
(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Revenue

₹25.04

Operating expense

₹20.59

Net income

₹3.85

Net profit margin

15.37%

Earning per share

₹6.14

EBITDA

₹6.01

Effective tax rate

23.1%

Particulars

Mar 24 (₹ value in crores)

Revenue

₹15.59

Operating expense

₹14.02

Net income

₹1.36

Net profit margin

8.72%

Earning per share

₹17.35

EBITDA

₹2.80

Effective tax rate

25.27%

Particulars

Mar 23 (₹ value in crores)

Revenue

₹6.54

Operating expense

₹5.77

Net income

₹1.06

Net profit margin

16.2%

Earning per share

₹15.09

EBITDA

₹2.17

Effective tax rate

25.53%

Particulars

Mar 22 (₹ value in crores)

Revenue

₹9.60

Operating expense

₹10.39

Net income

₹0.11

Net profit margin

1.14%

Earning per share

₹1.58

EBITDA

₹0.60

Effective tax rate

31.25%

(Values in Cr)
Revenue
Net income
(Values in Cr)
Revenue
Net income

Particulars (annual)

Mar 25 (₹ value in crores)

Book value per share

₹17.60

Return on Equity (ROE)

42.28%

Return on Capital Employed (ROCE)

36.73%

Total debt to equity ratio

0.77

EBITDA margin

24%

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

₹91.63

Return on Equity (ROE)

53%

Return on Capital Employed (ROCE)

37.65%

Total debt to equity ratio

1.32

EBITDA margin

25.39%

Particulars (annual)

Mar 23 (₹ value in crores)

Book value per share

₹28.37

Return on Equity (ROE)

72.6%

Return on Capital Employed (ROCE)

36.93%

Total debt to equity ratio

2.93

EBITDA margin

33.18%

Particulars (annual)

Mar 22 (₹ value in crores)

Book value per share

₹13.28

Return on Equity (ROE)

11.83%

Return on Capital Employed (ROCE)

13.75%

Total debt to equity ratio

3.56

EBITDA margin

6.25%

(Values in Cr)
Revenue
Net income
(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Cash and short term investments

₹0.19

Total assets

₹28.12

Total liabilities

₹28.12

Total equity

₹11.03

Shares outstanding

₹0.62

Price to book ratio

-

Return on assets (%)

13.69%

Return on capital

21.06%

Particulars

Mar 24 (₹ value in crores)

Cash and short term investments

-

Total assets

₹20.26

Total liabilities

₹20.26

Total equity

₹6.39

Shares outstanding

₹0.07

Price to book ratio

-

Return on assets (%)

6.71%

Return on capital

10.3%

Particulars

Mar 23 (₹ value in crores)

Cash and short term investments

₹0.12

Total assets

₹13.69

Total liabilities

₹13.69

Total equity

₹1.98

Shares outstanding

₹0.07

Price to book ratio

-

Return on assets (%)

7.71%

Return on capital

14.61%

Particulars

Mar 22 (₹ value in crores)

Cash and short term investments

₹0.13

Total assets

₹9.49

Total liabilities

₹9.49

Total equity

₹0.92

Shares outstanding

₹0.07

Price to book ratio

-

Return on assets (%)

1.16%

Return on capital

2.61%

(Values in Cr)
Revenue
Net income
(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Net income

₹5.01

Cash from operations

-

Cash from investing

₹0.73

Cash from financing

-₹0.51

Net change in cash

₹0.19

Free cash flow

₹0.01

Particulars

Mar 24 (₹ value in crores)

Net income

₹3.25

Cash from operations

-₹3.51

Cash from investing

-

Cash from financing

₹3.85

Net change in cash

-₹0.11

Free cash flow

-₹3.50

Particulars

Mar 23 (₹ value in crores)

Net income

₹1.41

Cash from operations

-₹0.30

Cash from investing

-₹0.91

Cash from financing

₹1.21

Net change in cash

-₹0.01

Free cash flow

-₹0.05

Particulars

Mar 22 (₹ value in crores)

Net income

₹0.15

Cash from operations

-₹1.15

Cash from investing

-

Cash from financing

₹1.29

Net change in cash

₹0.10

Free cash flow

-₹1.15

Asston Pharmaceuticals Limited technical summary

₹81.34
+ 1.67 ▲
2
Bearish
14
Bullish
5 Day81.1
10 Day82.2
12 Day82.5
20 Day83.4
26 Day83.9
50 Day85.9
100 Day91.5
200 Day95
5 Day81.4
10 Day82.8
12 Day83.2
20 Day83.8
26 Day84
50 Day86.7
100 Day89.8
200 Day0

80

PIVOT

First support
₹79.99
First resistance
₹80.00
Second support
₹79.99
Second resistance
₹80.01
Third support
₹79.98
Third resistance
₹80.01
RSI
38.84
ADX
18.37
MACD
-1.44
Williams % R
-94.79
Commodity Channel Index (CCI)
-191.55
Date
05 Feb 2026
Same day
4,000
Week
13,429
Month
7,591
1 year
0.01
3 years
0.02
Over 1 month
-4.76%
Over 1 year
-35.97%
Over 3 months
0%
Over 3 years
0%
Over 6 months
-33.05%
Over 6 years
0%

Investment Returns

Over 1 Month4.76%
Over 3 Months0%
Over 6 Months33.05%
Over 1 Year35.97%

Asston Pharmaceuticals Limited Shareholding pattern


Public
43.3%
Promoter holdings
50.66%
FII
6.03%
DII
0%
Promoter shares
0%
Promoter sharesShareCategory

Ashish Narayan Sakalkar

18,52,856 (21.77%)

Shareholding of Promoter and Promoter Group

Saili Jayaram More

18,52,856 (21.77%)

Shareholding of Promoter and Promoter Group

Sachin Chandrakant Badakh

6,06,768 (7.13%)

Shareholding of Promoter and Promoter Group

Mahesh Vishnupant Mulay

2,45,056 (2.88%)

Public Shareholding

Kuldip Singh Rathee

2,00,000 (2.35%)

Public Shareholding

Promoter sharesShareCategory
Ashish Narayan Sakalkar18,52,856 (21.77%)Shareholding of Promoter and Promoter Group
Saili Jayaram More18,52,856 (21.77%)Shareholding of Promoter and Promoter Group
Sachin Chandrakant Badakh6,06,768 (7.13%)Shareholding of Promoter and Promoter Group
Mahesh Vishnupant Mulay2,45,056 (2.88%)Public Shareholding
Kuldip Singh Rathee2,00,000 (2.35%)Public Shareholding
Minerva Ventures Fund1,63,000 (1.91%)Public Shareholding
Abundantia Capital Vcc- Abundantia Capital Iii1,22,000 (1.43%)Public Shareholding
Vrushali Yogesh Supekar1,20,466 (1.42%)Public Shareholding
Kingsman Wealth Fund Pcc Kif - Ll1,15,000 (1.35%)Public Shareholding
Vikasa India Eif I Fund - Incube Global Opportunities1,14,000 (1.34%)Public Shareholding
Dilip Rameshchandra Jagad1,06,672 (1.25%)Public Shareholding

About ASSTON PHARMACEUTICALS LIMITED

Asston Pharmaceuticals Limited was incorporated on 16th April 2019 as 'Asston Pharmaceutical Pvt. Limited' to contract produce pharmaceutical products for export market. Later on 1st April 2024, Company acquired Ferron Lifecare Private Limited, specializing into nutraceuticals business and produced nutraceutical products at their Ambarnath facility. Ferron Lifecare Private Limited, incorporated on 30th January 2020. Finally, 'Asston Pharmaceuticals Private Limited' was converted into a Public Limited Company in the name of 'Asston Pharmaceutica

Parent Organisation

Indian Private

NSE Symbol

ASSTON PHARMACEUTICALS LIMITED

Founded

2019

ASSTON PHARMACEUTICALS LIMITED CORPORATE ACTION

No data available.

View more stocks

What’s trending

All stocks

LOYALTEX

LOYAL TEXTILE MILLS LTD.

304.8
+50.8 (+20%)
GORANIN

GORANI INDUSTRIES LTD.

63.61
+10.6 (+20%)
NIRAJISPAT

NIRAJ ISPAT IND LTD

257.41
+42.9 (+20%)
STRATMONT

STRATMONT INDUSTRIES LIMITED

90.01
+15 (+20%)
View all

Top gainers

ITC

ITC LTD

325.8
+15.60 (+5.03%)
KOTAKBANK

KOTAK MAHINDRA BANK LTD

422.35
+13.60 (+3.33%)
HINDUNILVR

HINDUSTAN UNILEVER LTD.

2424.2
+69.80 (+2.96%)
BHARTIARTL

BHARTI AIRTEL LIMITED

2038.4
+46.00 (+2.31%)
View all

Top losers

HDFCLIFE

HDFC LIFE INS CO LTD

703.5
-17.20 (-2.39%)
TCS

TATA CONSULTANCY SERV LT

2941.6
-49.90 (-1.67%)
TECHM

TECH MAHINDRA LIMITED

1619.9
-26.30 (-1.60%)
BAJAJ-AUTO

BAJAJ AUTO LIMITED

9518.5
-128.50 (-1.33%)
View all

Frequently asked questions


Related videos


Related tags


You are here


Related links

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."


**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer


Powered by Bajaj Financial Securities Limited (Bajaj Broking)